Giselle Mosnaim to Adult
This is a "connection" page, showing publications Giselle Mosnaim has written about Adult.
Connection Strength
0.642
-
Asthma in Adults. Reply. N Engl J Med. 2023 11 30; 389(22):2112-3.
Score: 0.094
-
Asthma in Adults. N Engl J Med. 2023 Sep 14; 389(11):1023-1031.
Score: 0.093
-
Electronic medication monitoring versus self-reported use of inhaled corticosteroids and short-acting beta2-agonists in uncontrolled asthma. J Asthma. 2022 Oct; 59(10):2024-2027.
Score: 0.081
-
The Impact of Patient Self-Monitoring Via Electronic Medication Monitor and Mobile App Plus Remote Clinician Feedback on Adherence to Inhaled Corticosteroids: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 04; 9(4):1586-1594.
Score: 0.076
-
Harmonized outcome measures for use in asthma patient registries and clinical practice. J Allergy Clin Immunol. 2019 09; 144(3):671-681.e1.
Score: 0.068
-
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. Lancet Microbe. 2023 09; 4(9):e692-e703.
Score: 0.023
-
Preference for and impact of telehealth vs in-person asthma visits among Black and Latinx adults. Ann Allergy Asthma Immunol. 2023 11; 131(5):614-627.e2.
Score: 0.023
-
Early Outpatient Treatment for Covid-19 with Convalescent Plasma. N Engl J Med. 2022 05 05; 386(18):1700-1711.
Score: 0.021
-
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection. JCI Insight. 2022 03 08; 7(5).
Score: 0.021
-
A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients. Eur Respir J. 2021 06; 57(6).
Score: 0.020
-
Media Influence on Anxiety, Health Utility, and Health Beliefs Early in the SARS-CoV-2 Pandemic-a Survey Study. J Gen Intern Med. 2021 05; 36(5):1327-1337.
Score: 0.019
-
Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2-agonist in real-world patients with asthma. Allergy Asthma Proc. 2020 07 01; 41(4):248-255.
Score: 0.018
-
Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2310-2321.e4.
Score: 0.018
-
Development and validation of an asthma exacerbation prediction model using electronic health record (EHR) data. J Asthma. 2020 12; 57(12):1339-1346.
Score: 0.017
-
Family Chaos and Asthma Control. Pediatrics. 2019 08; 144(2).
Score: 0.017
-
Feasibility of percutaneous vagus nerve stimulation for the treatment of acute asthma exacerbations. Acad Emerg Med. 2012 Apr; 19(4):421-9.
Score: 0.010
-
Evaluation of an asthma medication training program for immigrant Mexican community health workers. Prog Community Health Partnersh. 2011; 5(1):95-103.
Score: 0.010
-
Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. Allergy Asthma Proc. 2010 Jan-Feb; 31(1):68-75.
Score: 0.009
-
In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine-enkephalin challenge. Immunopharmacology. 1993 Mar-Apr; 25(2):107-16.
Score: 0.003